Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)